Alere (ALR) volatility flat into Abbott Laboratories (ABT) agreeing to buy at $51 per share rather than previous offer of $56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Alere (ALR) PT Lowered to $51 at Canaccord Genuity
April 17, 2017 9:27 AM EDTCanaccord Genuity lowered its price target on Alere (NYSE: ALR) to $51.00 (from $52.00) while maintaining a Buy rating. ABT and ALR announced a settlement at $51/share, or ~21% higher than ALR's closing price of $42.31 last Thursday.
Canaccord believes that shareholders would have approved anything at $50+ so... More
Alere (ALR) PT Lowered to $51 at Jefferies Following Announced Revisions to ABT Merger
April 17, 2017 7:17 AM EDTJefferies lowered its price target on Alere (NYSE: ALR) to $51.00 (from $56.00) while maintaining a Hold rating following the company's announced amended the terms of to the merger with ABT.
Key revisions include: 1) $51/share vs. the original $56; 2) timeline extended to September 30 from April 30; and... More
